GOLDMAN SACHS GROUP INC - PANDION THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

PANDION THERAPEUTICS INC's ticker is PAND and the CUSIP is 698340106. A total of 76 filers reported holding PANDION THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PANDION THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$47,817,000
+12160.8%
796,286
+2935.0%
0.01%–
Q4 2020$390,000
+84.0%
26,237
+41.9%
0.00%–
Q3 2020$212,000–18,493–0.00%–
 Download
Other shareholders

There were no reported owners of PANDION THERAPEUTICS INC in Q1 2021.

NameSharesValueWeighting ↓
View complete list of PANDION THERAPEUTICS INC shareholders